» Articles » PMID: 34845714

How to Treat Incidental Pulmonary Embolism in Cancer Patients? Recent Advances

Overview
Journal Kardiol Pol
Date 2021 Nov 30
PMID 34845714
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with cancer have an increased risk of venous thromboembolism (VTE). In addition, due to the growing use of computed tomography scans in these patients and the improved scanners and imaging qualities, many cases of VTE are diagnosed incidentally on images obtained for reasons other than suspicion of VTE. Studies have shown that as many as half of all cancer-related pulmonary embolism (PE) cases could be incidental. Despite the common occurrence, the optimal management of incidental PE in patients with cancer remains unclear. This review will summarize pertinent literature related to incidental PE in the cancer population and discuss their outcomes and recommended treatments.

Citing Articles

Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism.

Stepien K, Zabczyk M, Kopytek M, Natorska J, Zalewski J, Undas A J Thromb Thrombolysis. 2023; 57(2):248-259.

PMID: 37932588 PMC: 10869393. DOI: 10.1007/s11239-023-02901-y.


Prognosis of incidental pulmonary embolism vs. symptomatic pulmonary embolism in cancer patients: a single-center retrospective cohort study in China.

Wang Y, Liu Z, Li Q, Xia L, Wang Y, Jiang D Thromb J. 2023; 21(1):64.

PMID: 37280671 PMC: 10245445. DOI: 10.1186/s12959-023-00502-6.


Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer.

Khorana A, Palaia J, Rosenblatt L, Pisupati R, Huang N, Nguyen C J Immunother Cancer. 2023; 11(1).

PMID: 36657815 PMC: 9853260. DOI: 10.1136/jitc-2022-006072.